Otezla (apremilast) is a brand-name oral tablet that’s prescribed for conditions such as psoriatic arthritis. The drug’s cost with and without insurance can depend on several factors, such as whether ...

--Amgen today announced Otezla ® improved measures of disease severity in adults with mild-to-moderate plaque psoriasis regardless of their Body Surface Area affected by the disease, according to ...

Biopharmaceutical giant Amgen announced Monday it has agreed to buy popular psoriasis and psoriatic-arthritis drug Otezla from Celgene for $13.4 billion. The deal helps clear the way for Amgen’s ...

Headache, upper respiratory infection, and nausea are some of Otezla’s more common side effects. As your body gets used to Otezla, some side effects may reduce or go away. This can take around 2 weeks ...

Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the skin.

Celgene’s oral psoriasis drug, Otezla (apremilast) looks set to become a blockbuster as sales leapt in Q2. Sales of Otezla were $242 million in Q2, a 170% increase compared with the corresponding ...

Amgen is ponying up $13.4 billion for Celgene’s psoriasis blockbuster Otezla. But it's not just getting the drug—it's also picking up the 800 to 900 Celgene employees who work on Otezla. And some ...

With the Federal Trade Commission (FTC) sweating the details of Bristol-Myers Squibb and Celgene’s proposed $74 billion merger, all eyes were on the companies’ combined psoriasis portfolio, which ...

THOUSAND OAKS, Calif., Aug. 26, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today that it has entered into an agreement with Celgene Corporation (NASDAQ: CELG) in connection with its ...

Your Otezla cost, with or without insurance, varies based on many factors. These include what pharmacy you use and your dose of Otezla. The best way to determine how much Otezla may cost you, with or ...